Effects of cardiopulmonary bypass perfusion temperature on perioperative renal function in adult patients undergoing cardiac surgery

被引:3
|
作者
Ramkumar, Jayavelan [1 ]
Gopinathan, Girish [1 ]
Kavin, Karthick [1 ]
Shanmugasundaram, Ramkumar [1 ]
Stephen, George Miller [1 ]
Pragasam, Annie Caroline [1 ]
Thangavel, Periyasamy [1 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res, Dept Cardiothorac Surg, Chennai 600116, Tamil Nadu, India
关键词
Acute kidney injury; Albuminuria; Cardiopulmonary bypass; Cardiac; Creatinine; Creatinine clearance; Heart valves; Hypothermia; Perfusion cardiac; ACUTE KIDNEY INJURY; REPERFUSION; PREDICTION; RESERVE;
D O I
10.37616/2212-5043.1007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims and objective: The primary objective of this investigation was to study the effects of cardiopulmonary bypass (CPB) perfusion temperature on renal function parameters [serum creatinine, creatinine clearance, urine albumin, urine protein, and urine albumin/creatinine ratio (ACR)]. The secondary objective was to detect renal complications of CPB. Materials and methods: This is a prospective longitudinal study of 30 adult patients (17 men, 13 women; mean age, 53.37 +/- 16.02 years) who underwent valvular heart surgery [with or without coronary artery bypass grafting (CABG)]. Serum creatinine, creatinine clearance, urine protein, urine albumin, and urine ACR were collected during CPB (at 28 degrees C, 32 degrees C, and 37 degrees C) and postoperatively (at 12 hours, 24 hours, and 48 hours). Data were analyzed using one-way repeated-measures analysis of variance (ANOVA). A significant ANOVA was followed by a Bonferroni-Holm post hoc test. Results: Although serum creatinine (p < 0.001) and creatinine clearance (p = 0.0016) underwent a significant ANOVA change (p < 0.001 and p = 0.0016, respectively) after CPB, there was no statistically significant change compared with their baseline values. Urine ACR showed a significant change at 28 degrees C (p < 0.01), 32 degrees C (p < 0.01), and 37 degrees C (p < 0.05) as compared with baseline values. No significant change in urine albumin was observed during CPB or up to 24 hours. A significant change occurred after 48 hours of CPB (p < 0.05). A significant increase in urine protein was noted after CPB at 12 hours (p < 0.01), 24 hours (p < 0.01), and 48 hours (p < 0.01). Overall, 12 (40%) patients had acute kidney injury (AKI). Ten (33.33%) patients had stage I AKI, one patient progressed to AKI stage II, and another to AKI stage III. Of the 10 patients who had stage I AKI, eight had complete recovery within 48 hours. Conclusions: CPB with moderate hypothermia for valvular heart surgeries can be performed safely in patients with adequate renal functional reserve. The glomerular permeability across the Bowman's capsule increases after CPB as evidenced by significant proteinuria at 12 hours and increased albuminuria at 48 hours after surgery. There is an increased risk of transient stage I AKI after CPB, from which patients recover within 48 hours.
引用
收藏
页码:40 / 45
页数:6
相关论文
共 50 条
  • [31] Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass
    Tsunehisa Tsubokawa
    Syuichi Ishizuka
    Kyoko Fukumoto
    Kazuyuki Ueno
    Ken Yamamoto
    Journal of Anesthesia, 2013, 27 : 243 - 250
  • [32] Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass
    Barbara, David W.
    Mauermann, William J.
    Neal, James R.
    Abel, Martin D.
    Schaff, Hartzell V.
    Winters, Jeffrey L.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (03): : 668 - 680
  • [33] Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass
    Tsubokawa, Tsunehisa
    Ishizuka, Syuichi
    Fukumoto, Kyoko
    Ueno, Kazuyuki
    Yamamoto, Ken
    JOURNAL OF ANESTHESIA, 2013, 27 (02) : 243 - 250
  • [34] Cardiopulmonary bypass alters the pharmacokinetics of propranolol in patients undergoing cardiac surgery
    Carmona, MJC
    Malbouisson, LMS
    Pereira, VA
    Bertoline, MA
    Omosako, CEK
    Le Bihan, KB
    Auler, JOC
    Santos, SRCJ
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (05) : 713 - 721
  • [35] Pharmacokinetics of dexmedetomidine in pediatric patients undergoing cardiac surgery with cardiopulmonary bypass
    Kim, Eun-Hee
    Choi, Byung-Moon
    Kang, Pyoyoon
    Lee, Ji-Hyun
    Kim, Hee-Soo
    Jang, Young-Eun
    Ji, Sang-Hwan
    Noh, Gyu-Jeong
    Cho, Joo-Youn
    Kim, Jin-Tae
    PEDIATRIC ANESTHESIA, 2023, 33 (04) : 303 - 311
  • [36] Antithrombin activity and outcomes in patients undergoing cardiac surgery with cardiopulmonary bypass
    Muedra, Vicente
    Barettino, Domingo
    D'Ocon, Pilar
    Zuniga, Angel
    Moreno, Lucrecia
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (04) : 454 - 457
  • [37] Kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass
    Poinsot, Pierre-Alain
    Barrucand, Benoit
    Ecarnot, Fiona
    Lassalle, Philippe
    Besch, Guillaume
    Chocron, Sidney
    Perrotti, Andrea
    CYTOKINE, 2018, 110 : 328 - 332
  • [38] Renal function and cardiopulmonary bypass in pediatric cardiac surgical patients
    Guillermo Lema
    Andrea Vogel
    Roberto Canessa
    Roberto Jalil
    Claudia Carvajal
    Pedro Becker
    Maria Paz Jaque
    Christian Fajardo
    Jorge Urzua
    Pediatric Nephrology, 2006, 21 : 1446 - 1451
  • [39] Renal function and cardiopulmonary bypass in pediatric cardiac surgical patients
    Lema, Guillermo
    Vogel, Andrea
    Canessa, Roberto
    Jalil, Roberto
    Carvajal, Claudia
    Becker, Pedro
    Jaque, Maria Paz
    Fajardo, Christian
    Urzua, Jorge
    PEDIATRIC NEPHROLOGY, 2006, 21 (10) : 1446 - 1451
  • [40] Use of Albumin Solution in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
    Zhou, Yongqi
    Zhu, Tao
    Chen, Chan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (20): : 2067 - 2067